Nautilus Biotechnology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $398.5M
Liabilities Breakdown FY2021
Total Liabilities: $34.9M
Asset Breakdown
Total Assets: $398.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $185.6M | 46.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.5M | 0.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $210.3M | 52.8% |
Liabilities Breakdown
Total Liabilities: $34.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 4.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $33.2M | 95.1% |